Use of antithrombotic therapy for secondary prevention in patients with stable atherosclerotic cardiovascular disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT-CVD) study.
Sanam VermaShaun G GoodmanMary K TanBenoit DaneaultBruce J LubelskySamer MansourAndy S LamDavid LaflammeWayne J TymchakRobert C WelshRandi C RoseRajendra M ChettyChristian M ConstanceTomas CiezaBrian J PotterMichael C HartleibRazi KhanRichard F ChoiWilliam KeebleJean-Pierre DeryDinkar ShuklaGrace L ChuaKevin R BaineyPublished in: International journal of clinical practice (2021)
In contemporary Canadian clinical practice of stable ASCVD patients, a large number of patients receive antithrombotic therapy other than SAPT. Further efforts are required to guide the appropriate selection of patients in whom more potent antithrombotic therapies may safely reduce residual risk.